Skip to main navigation Skip to search Skip to main content

Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, may 2, 2018

  • NICOLAS S. Piuzzi
  • , M. DOMINICI
  • , M. A.R.C. LONG
  • , C. PASCUAL-GARRIDO
  • , S. RODEO
  • , J. HUARD
  • , JÉROME GUICHEUX
  • , R. MCFARLAND
  • , LAURIE R. GOODRICH
  • , STÉPHANE MADDENS
  • , PAMELA G. ROBEY
  • , THOMAS W. BAUER
  • , J. O.H.N. BARRETT
  • , F. BARRY
  • , D. KARLI
  • , CONSTANCE R. CHU
  • , DANIEL J. WEISS
  • , I. V.A.N. MARTIN
  • , C. JORGENSEN
  • , GEORGE F. MUSCHLER
  • Cleveland Clinic Foundation
  • Instituto Universitario del Hospital Italiano de Buenos Aires
  • University Hospital of Modena
  • MTF Biologics
  • Washington University in St. Louis
  • Hospital for Special Surgery - New York
  • University of Texas
  • Steadman Philippon Research Institute
  • Inserm
  • Advanced Regenerative Manufacturing Institute
  • Colorado State University
  • Vetbiobank
  • National Institute of Dental and Craniofacial Research (NIDCR)
  • National Institutes of Health (NIH)
  • Greyledge Technologies, LLC
  • Stanford University
  • Palo Alto Veterans Administration Medical Center
  • University of Vermont Larner College of Medicine
  • University Hospital Basel
  • Lapeyronie University Hospital

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

37 Citations (Scopus)

Abstract

The Signature Series Symposium “Cellular Therapies for Orthopaedics and Musculoskeletal Disease Proven and Unproven Therapies—Promise, Facts and Fantasy” was held as a pre-meeting of the 26th International Society for Cellular Therapy (ISCT) annual congress in Montreal, Canada, May 2, 2018. This was the first ISCT program that was entirely dedicated to the advancement of cell-based therapies for musculoskeletal diseases. Cellular therapies in musculoskeletal medicine are a source of great promise and opportunity. They are also the source of public controversy, confusion and misinformation. Patients, clinicians, scientists, industry and government share a commitment to clear communication and responsible development of the field. Therefore, this symposium convened thought leaders from around the world in a forum designed to catalyze communication and collaboration to bring the greatest possible innovation and value to patients with musculoskeletal conditions.

Original languageEnglish
Pages (from-to)1381-1400
Number of pages20
JournalCytotherapy
Volume20
Issue number11
DOIs
Publication statusPublished - Nov 2018

Fingerprint

Dive into the research topics of 'Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, may 2, 2018'. Together they form a unique fingerprint.

Cite this